Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

119.33p
   
  • Change Today:
    -1.17p
  • 52 Week High: 134.00
  • 52 Week Low: 84.50
  • Currency: UK Pounds
  • Shares Issued: 84.77m
  • Volume: 41,899
  • Market Cap: £101.16m
  • RiskGrade: 196
  • Beta: 0.15

Diaceutics strikes 'groundbreaking' enterprise promotional partnership

By Iain Gilbert

Date: Monday 19 Aug 2024

LONDON (ShareCast) - (Sharecast News) - Technology and solutions provider Diaceutics has struck a "groundbreaking enterprise promotional partnership" with a "leading biotech" firm worth up to £4.3m over 18 months.
Diaceutics said on Monday that it will become the unnamed client's primary promotional partner for the launch of a breakthrough oncology precision medicine in the US using its PMx suite of data-driven services built for the promotion and commercialisation of precision medicine.

The AIM-listed firm stated the partnership represented its seventh enterprise-wide engagement and the first PMx primary promotional partnership deal in which its fee structure was aligned with patient recruitment onto therapy.

"PMx unlocks new revenue streams for Diaceutics and shows the path to considerable increase in revenue per brand," said Diaceutics.

"This agreement is to deploy PMx through to the end of 2025 and is worth at least £2.4min service revenue to Diaceutics, with additional milestone fees estimated to be worth another £1.9m payable during that period based on successful patient recruitment onto therapy. There is an expectation that the agreement will extend beyond 2025 should the initial phase be successful."

As of 0930 BST, Diaceutics shares were up 6.35% at 131.88p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 119.33p
Change Today -1.17p
% Change -0.97 %
52 Week High 134.00
52 Week Low 84.50
Volume 41,899
Shares Issued 84.77m
Market Cap £101.16m
Beta 0.15
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.79% below the market average35.79% below the market average35.79% below the market average35.79% below the market average35.79% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Price Trend
59.20% above the market average59.20% above the market average59.20% above the market average59.20% above the market average59.20% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth
20.34% above the market average20.34% above the market average20.34% above the market average20.34% above the market average20.34% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 12-Dec-2024

Time Volume / Share Price
11:00 2,500 @ 122.00p
11:00 2,500 @ 122.00p
10:36 6,000 @ 118.00p
09:17 2,000 @ 120.00p
08:16 12,621 @ 119.25p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page